Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
ethynylestradiol 0,05 mg + levonorgestrel 0,25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ethynylestradiol 0,05 mg + levonorgestrel 0,25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
ethynylestradiol 0,035 mg + norethindron 0,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ethynylestradiol 0,035 mg + norethindron 0,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely ethinylestradiol 50 microgram and norgestrel 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 50 microgram and norgestrel 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
hydrochlorthiazid 12,5 mg + quinaprilhydrochlorid 20 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
hydrochlorthiazid 12,5 mg + quinaprilhydrochlorid 20 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
hydrochlorthiazid 25 mg + quinaprilhydrochlorid 20 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
hydrochlorthiazid 25 mg + quinaprilhydrochlorid 20 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Dexmethylphenidate hydrochloride 2.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dexmethylphenidate hydrochloride 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dexmethylphenidate hydrochloride 10 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely dutasteride 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Disulfiram 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
dexamphetaminsulfat 10 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dicycloverine hydrochloride 20 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Guaifenesin 100 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Guaifenesin 200 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine sulfate 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely fenoprofen calcium 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dofetilide 125 microgram oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely dofetilide 250 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Furosemide 80 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Efavirenz 600 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Desogestrel 75 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Estradiol 4 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
clemastin 1,34 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ferrous sulfate 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Eplerenone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |